173 related articles for article (PubMed ID: 14628438)
1. Diagnostic application of FISH to hematological malignancies.
Najfeld V
Cancer Invest; 2003; 21(5):807-14. PubMed ID: 14628438
[No Abstract] [Full Text] [Related]
2. [Essentials of conventional and molecular cytogenetics: application to diagnosis of hematological malignancies].
Lafage-Pochitaloff M
Pathol Biol (Paris); 2003 Aug; 51(6):307-11. PubMed ID: 12927887
[No Abstract] [Full Text] [Related]
3. The impact of the new fish technologies on the cytogenetics of haematological malignancies.
Kearney L
Br J Haematol; 1999 Mar; 104(4):648-58. PubMed ID: 10192422
[No Abstract] [Full Text] [Related]
4. [The hematological malignancies related to primary hypereosinophilia and their diagnostics].
Skonieczka K; Matiakowska K; Haus O
Postepy Hig Med Dosw (Online); 2014 Dec; 68():1530-7. PubMed ID: 25834096
[TBL] [Abstract][Full Text] [Related]
5. The use of new technologies in the detection of balanced translocations in hematologic disorders.
Shaffer LG; Schultz RA; Ballif BC
Curr Opin Genet Dev; 2012 Jun; 22(3):264-71. PubMed ID: 22336526
[TBL] [Abstract][Full Text] [Related]
6. [Cytogenetics and molecular genetics of hematological malignancy].
Izutsu K
Nihon Rinsho; 2007 Jan; 65 Suppl 1():304-8. PubMed ID: 17474424
[No Abstract] [Full Text] [Related]
7. [Fluorescence in situ hybridization in hematology].
Milosević I; Popović S; Urosević I
Vojnosanit Pregl; 2012 Nov; 69(11):986-93. PubMed ID: 23311251
[No Abstract] [Full Text] [Related]
8. [FISH, interphase cytogenetics, gene rearrangements].
Taniwaki M
Rinsho Ketsueki; 1998 Feb; 39(2):75-7. PubMed ID: 9545801
[No Abstract] [Full Text] [Related]
9. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
10. FISH panels for hematologic malignancies.
Sreekantaiah C
Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
[TBL] [Abstract][Full Text] [Related]
11. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
12. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies].
Nara N
Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952
[No Abstract] [Full Text] [Related]
13. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
Taniwaki M
Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
[No Abstract] [Full Text] [Related]
14. Molecular genetic methods in the diagnosis of hematologic neoplasms.
Sen F; Vega F; Medeiros LJ
Semin Diagn Pathol; 2002 May; 19(2):72-93. PubMed ID: 12036283
[TBL] [Abstract][Full Text] [Related]
15. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
16. [Application of new FISH techniques for cytogenetic analysis in hematological malignancies].
Kakazu N; Abe T
Rinsho Ketsueki; 2002 May; 43(5):316-8. PubMed ID: 12096476
[No Abstract] [Full Text] [Related]
17. High-resolution copy number array in the molecular cytogenetic diagnostics of pediatric malignant hematological disorders.
Wikhager C; Ögärd I; Martinsson T; Abrahamsson J; Palmqvist L; Sjögren H
Oncol Rep; 2012 May; 27(5):1429-34. PubMed ID: 22344473
[TBL] [Abstract][Full Text] [Related]
18. Incidence of submicroscopic deletions vary according to disease entities and chromosomal translocations in hematologic malignancies: investigation by fluorescence in situ hybridization.
Moon HW; Chang YH; Kim TY; Oh BR; Min HC; Kim BK; Ahn HS; Cho HI; Lee DS
Cancer Genet Cytogenet; 2007 Jun; 175(2):166-8. PubMed ID: 17556074
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements.
Madrigal I; Carrió A; Gómez C; Rozman M; Esteve J; Nomdedeu B; Campo E; Costa D
Cancer Genet Cytogenet; 2006 Oct; 170(2):115-20. PubMed ID: 17011981
[TBL] [Abstract][Full Text] [Related]
20. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
